• Therapie der Zukunft: we fight your cancer

Working group under Prof. Hartenbach shows outstanding diagnostic value of PSMA PET/MRI in prostate cancer

Working group headed by Prof. Markus Hartenbach was able to demonstrate the outstanding diagnostic value of PSMA PET / MRI in biopsy-proven prostate cancer. PSMA-PET/MRI can provide an accurate staging of newly diagnosed prostate cancer. In addition, treatment strategies were changed in almost a third of the patients due to the information of this hybrid imaging technique. The scientific paper was published in the Clinical Cancer Research journal.


Leave a Reply